25
https://pubmed.ncbi.nlm.nih.gov/38112540
This study finds that a specific signature of gut microbiome can predict hepatitis B virus-related hepatocellular carcinoma patients with microvascular invasion, suggesting its potential as a non-invasive biomarker.